Skip to main content

Market Overview

The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace

Share:
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE). Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects.

Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc (NASDAQ: VSTM) became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77  before recovering some lost ground.

Here are the key catalysts for the unfolding week.

Conferences

SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6
Maxim Group M-Vest Infectious Disease Virtual Conference: May 5

Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio

Clinical Readouts

Adverum Biotechnologies Inc (NASDAQ: ADVM) is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.

Auris Medical Holding Ltd (NASDAQ: EARS) is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.

Early Q2 Schedule

Ovid Therapeutics Inc (NASDAQ: OVID): Phase 2 top-line data for OV101 in Fragile X syndrome

Iterum Therapeutics PLC (NASDAQ: ITRM): Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections

Enanta Pharmaceuticals Inc (NASDAQ: ENTA): data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis

Earnings

Monday

Marinus Pharmaceuticals Inc (NASDAQ: MRNS) (before the market open)
Minerva Neurosciences Inc (NASDAQ: NERV) (before the market open)
Epizyme Inc (NASDAQ: EPZM) (before the market open)
SI-Bone Inc (NASDAQ: SIBN) (after the market close)
Corcept Therapeutics Incorporated (NASDAQ: CORT) (after the market close)
Chembio Diagnostics Inc (NASDAQ: CEMI) (after the market close)
GenMark Diagnostics, Inc (NASDAQ: GNMK) (after the market close)
Kura Oncology Inc (NASDAQ: KURA) (after the market close)
Varian Medical Systems, Inc. (NYSE: VAR) (after the market close)
Fulgent Genetics Inc (NASDAQ: FLGT) (after the market close)

See Also: Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine

Tuesday

Oxford Immunotec Global PLC (NASDAQ: OXFD) (before the market open)
Karyopharm Therapeutics Inc (NASDAQ: KPTI) (before the market open)
Haemonetics Corporation (NYSE: HAE) (before the market open)
Antares Pharma Inc (NASDAQ: ATRS) (before the market open)
Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open)
Vericel Corp (NASDAQ: VCEL) (before the market open)
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) (before the market open)
Neuronetics Inc (NASDAQ: STIM) (before the market open)
Mallinckrodt PLC (NYSE: MNK) (before the market open)
Akebia Therapeutics Inc (NASDAQ: AKBA) (before the market open)
Agile Therapeutics Inc (NASDAQ: AGRX) (after the market close)
Aquestive Therapeutics Inc (NASDAQ: AQST) (after the market close)
Akcea Therapeutics Inc (NASDAQ: AKCA) (after the market close)
Acorda Therapeutics Inc (NASDAQ: ACOR) (after the market close)
Axonics Modulation Technologies Inc (NASDAQ: AXNX) (after the market close)
Synthetic Biologics Inc (NYSE: SYN) (after the market close)
T2 Biosystems Inc (NASDAQ: TTOO) (after the market close)
Iovance Biotherapeutics Inc (NASDAQ: IOVA) (after the market close)
MacroGenics Inc (NASDAQ: MGNX) (after the market close)
Zogenix, Inc. (NASDAQ: ZGNX) (after the market close)
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) (after the market close)
Exelixis, Inc. (NASDAQ: EXEL) (after the market close)
Myriad Genetics, Inc. (NASDAQ: MYGN) (after the market close)
Inspire Medical Systems Inc (NYSE: INSP) (after the market close)
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) (after the market close)
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) (after the market close)
Nevro Corp (NYSE: NVRO) (after the market close)
Clovis Oncology Inc (NASDAQ: CLVS) (after the market close)
InVitae Corp (NYSE: NVTA) (after the market close)
Cytosorbents Corp (NASDAQ: CTSO) (after the market close)
Cardiovascular Systems Inc (NASDAQ: CSII) (after the market close)
Cerus Corporation (NASDAQ: CERS) (after the market close)
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) (after the market close)
Incyte Corporation (NASDAQ: INCY) (after the market close)
Orthopediatrics Corp (NASDAQ: KIDS) (after the market close)

Wednesday

Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) (before the market open)
Horizon Therapeutics PLC (NASDAQ: HZNP) (before the market open)
Constellation Pharmaceuticals Inc (NASDAQ: CNST) (before the market open)
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (before the market open)
IVERIC bio Inc (NASDAQ: ISEE) (before the market open)
Blueprint Medicines Corp (NASDAQ: BPMC) (before the market open)
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) (before the market open)
Strongbridge Biopharma plc (NASDAQ: SBBP) (before the market open)
Evofem Biosciences, Inc. (NASDAQ: EVFM) (before the market open)
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) (before the market open)
Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open)
PPD Inc (NASDAQ: PPD) (before the market open)
Zoetis Inc (NYSE: ZTS) (before the market open)
Ionis Pharmaceuticals Inc (NASDAQ: IONS) (before the market open)
TherapeuticsMD Inc (NASDAQ: TXMD) (before the market open)
Avanos Medical Inc (NYSE: AVNS) (before the market open)
Aerie Pharmaceuticals Inc (NASDAQ: AERI) (after the close)
Allogene Therapeutics Inc (NASDAQ: ALLO) (after the close)
ADMA Biologics Inc (NASDAQ: ADMA) (after the close)
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (after the close)
AxoGen, Inc Common Stock (NASDAQ: AXGN) (after the close)
Global Blood Therapeutics Inc (NASDAQ: GBT) (after the close)
Pacific Biosciences of California (NASDAQ: PACB) (after the close)
Theravance Biopharma Inc (NASDAQ: TBPH) (after the close)
BioTelemetry Inc (NASDAQ: BEAT) (after the close)
Bio-Rad Laboratories, Inc. (NYSE: BIO) (after the close)
Veracyte Inc (NASDAQ: VCYT) (after the close)
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) (after the close)
Precigen Inc (NASDAQ: PGEN) (after the close)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (after the close)
OraSure Technologies, Inc. (NASDAQ: OSUR) (after the close)
NuVasive, Inc. (NASDAQ: NUVA) (after the close)
Sarepta Therapeutics Inc (NASDAQ: SRPT) (after the close)
Natera Inc (NASDAQ: NTRA) (after the close)
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) (after the close)
Qiagen NV (NYSE: QGEN) (after the close)
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) (after the close)
Esperion Therapeutics Inc (NASDAQ: ESPR) (after the close)
G1 Therapeutics Inc (NASDAQ: GTHX) (after the close)
Quidel Corporation (NASDAQ: QDEL) (after the close)
Cytokinetics, Inc. (NASDAQ: CYTK) (after the close)
MannKind Corporation (NASDAQ: MNKD) (after the close)

Thursday

Integra Lifesciences Holdings Corp (NASDAQ: IART) (before the market open)
Intra-Cellular Therapies Inc (NASDAQ: ITCI) (before the market open)
Endo International PLC (NASDAQ: ENDP) (before the market open)
Xeris Pharmaceuticals Inc (NASDAQ: XERS) (before the market open)
Moderna Inc (NASDAQ: MRNA) (before the market open)
Syros Pharmaceuticals Inc (NASDAQ: SYRS) (before the market open)
Elanco Animal Health Inc (NYSE: ELAN) (before the market open)
Athenex Inc (NASDAQ: ATNX) (before the market open)
Aldeyra Therapeutics Inc (NASDAQ: ALDX) (before the market open)
Albireo Pharma Inc (NASDAQ: ALBO) (before the market open)
ANI Pharmaceuticals Inc (NASDAQ: ANIP) (before the market open)
Agenus Inc (NASDAQ: AGEN) (before the market open)
Amicus Therapeutics, Inc. (NASDAQ: FOLD) (before the market open)
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) (before the market open)
Bristol-Myers Squibb Co (NYSE: BMY) (before the market open)
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) (before the market open)
X4 Pharmaceuticals Inc (NASDAQ: XFOR) (before the market open)
Miragen Therapeutics Inc (NASDAQ: MGEN) (before the market open)
Kala Pharmaceuticals Inc (NASDAQ: KALA) (before the market open)
Seres Therapeutics Inc (NASDAQ: MCRB) (before the market open)
Intellia Therapeutics Inc (NASDAQ: NTLA) (before the market open)
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) (before the market open)
Editas Medicine Inc (NASDAQ: EDIT) (before the market open)
Pacira Biosciences Inc (NASDAQ: PCRX) (before the market open)
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) (after the close)
Tricida Inc (NASDAQ: TCDA) (after the close)
Helius Medical Technologies Inc (NASDAQ: HSDT) (after the close)
Twist Bioscience Corp (NASDAQ: TWST) (after the close)
Athersys Inc (NASDAQ: ATHX) (after the close)
Accelerate Diagnostics Inc (NASDAQ: AXDX) (after the close)
Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (after the close)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) (after the close)
Anika Therapeutics Inc (NASDAQ: ANIK) (after the close)
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) (after the close)
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) (after the close)
Calithera Biosciences Inc (NASDAQ: CALA) (after the close)
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) (after the close)
Puma Biotechnology Inc (NASDAQ: PBYI) (after the close)
Coherus Biosciences Inc (NASDAQ: CHRS) (after the close)
Kindred Biosciences Inc (NASDAQ: KIN) (after the close)
PDL BioPharma Inc (NASDAQ: PDLI) (after the close)
Rockwell Medical Inc (NASDAQ: RMTI) (after the close)
Penumbra Inc (NYSE: PEN) (after the close)
Pfenex Inc (NYSE: PFNX) (after the close)
ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) (after the close)
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) (after the close)
ICU Medical Inc (NASDAQ: ICUI) (after the close)
Nektar Therapeutics (NASDAQ: NKTR) (after the close)
Savara Inc (NASDAQ: SVRA) (after the close)
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) (after the close)
OptiNose Inc (NASDAQ: OPTN) (after the close)
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) (after the close)
Five Prime Therapeutics Inc (NASDAQ: FPRX) (after the close)
Flexion Therapeutics Inc (NASDAQ: FLXN) (after the close)
FibroGen Inc (NASDAQ: FGEN) (after the close)
Globus Medical Inc (NYSE: GMED) (after the close)
Guardant Health Inc (NASDAQ: GH) (after the close)
OpGen Inc (NASDAQ: OPGN) (after the close)
Lineage Cell Therapeutics Inc (NYSE: LCTX) (after the close)
Dynavax Technologies Corporation (NASDAQ: DVAX) (after the close)
Chiasma Inc (NASDAQ: CHMA) (after the close)
Collegium Pharmaceutical Inc (NASDAQ: COLL) (after the close)
Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) (after the close)
Caladrius Biosciences Inc (NASDAQ: CLBS) (after the close)
Glaukos Corp (NYSE: GKOS) (after the close)
Celcuity Inc (NASDAQ: CELC) (after the close)
Codexis, Inc. (NASDAQ: CDXS) (after the close)
CytomX Therapeutics Inc (NASDAQ: CTMX) (after the close)
Insulet Corporation (NASDAQ: PODD) (after the close)

Friday

Meridian Bioscience, Inc. (NASDAQ: VIVO) (before the market open)
Mersana Therapeutics Inc (NASDAQ: MRSN) (before the market open)
Ocular Therapeutix Inc (NASDAQ: OCUL) (before the market open)

 

Related Articles (XBI + IBB)

View Comments and Join the Discussion!

Posted-In: Biotech Earnings News Health Care Previews Trading Ideas General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com